April 23, 2026 - 00:33

In a significant move to accelerate the future of high-speed data connectivity, Marvell Technology has announced the acquisition of Polariton Technologies, a leader in silicon photonics innovation. This strategic acquisition is set to enhance Marvell's optical roadmap by integrating cutting-edge plasmonics-based modulation technology and a team with deep expertise in silicon photonics.
The deal centers on Polariton's advanced optical solutions, which are critical for scaling data center and cloud infrastructure performance. Specifically, the acquired technology is designed to push optical performance scaling to 3.2 terabits per second and beyond, addressing the exploding demand for bandwidth driven by artificial intelligence and machine learning applications.
By incorporating Polariton's plasmonic-photonic technology, Marvell aims to develop more efficient, higher-capacity optical interconnects. These components are essential for linking servers and switches within massive data centers, forming the backbone of modern cloud computing. The addition of Polariton's specialized engineering team further strengthens Marvell's in-house capabilities to innovate at the physical layer of connectivity.
This acquisition underscores the industry's urgent need to move beyond traditional electrical interconnects, which face increasing limitations in speed and power efficiency over distance. Marvell's investment signals a commitment to leading the transition towards advanced photonic solutions that will power the next generation of global data infrastructure.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...